Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reimbursement Expansion To Fuel China Pharma Growth In 2011 (Part 1 of 2)

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - China's pharmaceutical market is expected to grow around 26% in the coming year with much of the growth fueled by continued implementation of the government's Essential Drug List (EDL) and reimbursement expansion via government insurance plans, said Katherine Lu, senior analyst for China healthcare at Oppenheimer & Co
Advertisement

Related Content

Are China's Rising Labor Costs Good For Big Pharma?
Is China A Black Swan For Big Pharma? (Part 2 of 2)
Insider Analysis From Datamonitor: Awareness Of China's Regional Disparities Crucial For Commercial Success
China Should Step Up Funding For Rural Health Facilities, Medical Devices In New Five-Year Plan - EU Chamber Of Commerce In China
Cost Of China Healthcare Reforms Exceeds RMB 1 Trillion; Government Raises Reimbursement Ceilings
Chinese Premier, In Rare Online Chat, Pledges Higher Levels Of State Reimbursement For Medical Care And Insurance
Innovation To Drive Long-Term Survival In China Pharma Market - But What Kind Of Innovation?
Expansion Into China's Lower-Tier Cities Could Be Growth Driver For Big Pharma
Expansion Into China's Lower-tier Cities Could Be Growth Driver For Big Pharma
China's Pro-science Leaders To Make Biotech Drugs A Central Plank In New Five Year Plan
Advertisement
UsernamePublicRestriction

Register

SC077204

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel